Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6578930rdf:typepubmed:Citationlld:pubmed
pubmed-article:6578930lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:6578930lifeskim:mentionsumls-concept:C0268146lld:lifeskim
pubmed-article:6578930lifeskim:mentionsumls-concept:C0311400lld:lifeskim
pubmed-article:6578930lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:6578930lifeskim:mentionsumls-concept:C0221099lld:lifeskim
pubmed-article:6578930pubmed:issue4lld:pubmed
pubmed-article:6578930pubmed:dateCreated1983-12-20lld:pubmed
pubmed-article:6578930pubmed:abstractTextTo elucidate the basis for the recurrent infections in patients with glycogen storage disease (GSD) Ib we tested polymorphonuclear leukocyte (PMN) function in one patient. Bactericidal capacity and phagocytosis-induced O2 consumption were reduced. Also, phorbol myristate acetate-stimulated superoxide production and glucose oxidation through the hexose monophosphate shunt were diminished compared to control subjects. Therefore it could be speculated that in PMN of patients with GSD Ib, glucose-6-phosphate has no access to the enzymes of the hexose monophosphate shunt due to a transport-related defect as shown for glucogenesis in hepatocytes.lld:pubmed
pubmed-article:6578930pubmed:languageenglld:pubmed
pubmed-article:6578930pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6578930pubmed:citationSubsetIMlld:pubmed
pubmed-article:6578930pubmed:statusMEDLINElld:pubmed
pubmed-article:6578930pubmed:monthSeplld:pubmed
pubmed-article:6578930pubmed:issn0340-6199lld:pubmed
pubmed-article:6578930pubmed:authorpubmed-author:GahrMMlld:pubmed
pubmed-article:6578930pubmed:authorpubmed-author:HeyneKKlld:pubmed
pubmed-article:6578930pubmed:issnTypePrintlld:pubmed
pubmed-article:6578930pubmed:volume140lld:pubmed
pubmed-article:6578930pubmed:ownerNLMlld:pubmed
pubmed-article:6578930pubmed:authorsCompleteYlld:pubmed
pubmed-article:6578930pubmed:pagination329-30lld:pubmed
pubmed-article:6578930pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6578930pubmed:meshHeadingpubmed-meshheading:6578930-...lld:pubmed
pubmed-article:6578930pubmed:meshHeadingpubmed-meshheading:6578930-...lld:pubmed
pubmed-article:6578930pubmed:meshHeadingpubmed-meshheading:6578930-...lld:pubmed
pubmed-article:6578930pubmed:meshHeadingpubmed-meshheading:6578930-...lld:pubmed
pubmed-article:6578930pubmed:meshHeadingpubmed-meshheading:6578930-...lld:pubmed
pubmed-article:6578930pubmed:meshHeadingpubmed-meshheading:6578930-...lld:pubmed
pubmed-article:6578930pubmed:meshHeadingpubmed-meshheading:6578930-...lld:pubmed
pubmed-article:6578930pubmed:year1983lld:pubmed
pubmed-article:6578930pubmed:articleTitleImpaired metabolic function of polymorphonuclear leukocytes in glycogen storage disease Ib.lld:pubmed
pubmed-article:6578930pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6578930pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:6578930pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6578930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6578930lld:pubmed